Body mass index as a standard measure of healthy or unhealthy weight, is once again being called into question with the American Medical Association recommending physicians deemphasize BMI in patient care and employ other ways to address weight.
SNK-396 by Synerk for Lipid Disorders: Likelihood of Approval
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes